1. Treatment of AL amyloidosis in 2012; the benefit of new drugs (bortezomib, thalidomide, and lenalidomide). Summary of published clinical trials;Adam;Vnitr̆ní Lékar̆ství,2013
2. Thalidomide and thalidomide analogues for maintenance of remission in Crohn’s disease;Akobeng;Cochrane Database Syst. Rev.,2009
3. The evolution of thalidomide and its IMiD derivatives as anticancer agents;Bartlett;Nat. Rev. Cancer,2004
4. Currents concepts on the immunopathology of amyloidosis;Bhat;Clin. Rev. Allergy Immunol.,2010
5. Lenalidomide/melphalan/dexamethasone chemotherapy in 50 patients with newly diagnosed amyloid light chain amyloidosis: first results of a prospective single center phase 2 study (Leomex);Bochtler;Blood,2013